Skip to main content
Log in

Nociceptin system as a target in sepsis?

  • Invited Review Article
  • Published:
Journal of Anesthesia Aims and scope Submit manuscript

Abstract

The nociceptin system comprises the nociceptin receptor (NOP) and the ligand nociceptin/orphanin FQ (N/OFQ) that binds to the receptor. The archetypal role of the system is in pain processing but the NOP receptor is also expressed on immune cells. Activation of the NOP receptor is known to modulate inflammatory responses, such as mast-cell degranulation, neutrophil rolling, vasodilation, increased vascular permeability, adhesion molecule regulation and leucocyte recruitment. As there is a loss of regulation of inflammatory responses during sepsis, the nociceptin system could be a target for therapies aimed at modulating sepsis. This review details the known effects of NOP activation on leucocytes and the vascular endothelium and discusses the most recent human and animal data on the role of the nociceptin system in sepsis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Sriskandan S, Altmann D. The immunology of sepsis. J Pathol. 2008;214:211–23.

    Article  PubMed  CAS  Google Scholar 

  2. Jawad I, Lukšić I, Rafnsson SB. Assessing available information on the burden of sepsis: global estimates of incidence, prevalence and mortality. J Glob Health. 2012;2:010404.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Martin GS. Sepsis, severe sepsis and septic shock: changes in incidence, pathogens and outcomes. Expert Rev Anti Infect Ther. 2012;10:701–6.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  4. Vincent J-L, Sakr Y, Sprung CL, Ranieri VM, Reinhart K, Gerlach H, Moreno R, Carlet J, Le Gall J-R, Payen D. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med. 2006;34:344–53.

    Article  PubMed  Google Scholar 

  5. Serrano-Gomez A, Thompson J, Lambert D. Nociceptin/orphanin FQ in inflammation and sepsis. Br J Anaesth. 2011;106:6–12.

    Article  PubMed  CAS  Google Scholar 

  6. Gavioli EC, Romao PR. NOP receptor ligands as potential agents for inflammatory and autoimmune diseases. J Amino Acids. 2011;2011:836569.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Reinscheid RK, Nothacker H-P, Bourson A, Ardati A, Henningsen RA, Bunzow JR, Grandy DK, Langen H, Monsma FJ, Civelli O. Orphanin FQ: a neuropeptide that activates an opioid like G protein-coupled receptor. Science. 1995;270:792–4.

    Article  PubMed  CAS  Google Scholar 

  8. Lambert DG. The nociceptin/orphanin FQ receptor: a target with broad therapeutic potential. Nat Rev Drug Discov. 2008;7:694–710.

    Article  PubMed  CAS  Google Scholar 

  9. Pampusch MS, Serie JR, Osinski MA, Seybold VS, Murtaugh MP, Brown DR. Expression of nociceptin/OFQ receptor and prepro-nociceptin/OFQ in lymphoid tissues. Peptides. 2000;21:1865–70.

    Article  PubMed  CAS  Google Scholar 

  10. Arjomand J, Cole S, Evans CJ. Novel orphanin FQ/nociceptin transcripts are expressed in human immune cells. J Neuroimmunol. 2002;130:100–8.

    Article  PubMed  CAS  Google Scholar 

  11. Miller TR, Fulford AJ. Regulation of nociceptin/orphanin FQ secretion by immune cells and functional modulation of interleukin-2. Peptides. 2007;28:2243–52.

    Article  PubMed  CAS  Google Scholar 

  12. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent J-L, Ramsay G. 2001 sccm/esicm/accp/ats/sis international sepsis definitions conference. Intensive Care Med. 2003;29:530–8.

    Article  PubMed  Google Scholar 

  13. Kimura T, Kitaichi K, Hiramatsu K, Yoshida M, Ito Y, Kume H, Yamaki K, Suzuki R, Takagi K. Intradermal application of nociceptin increases vascular permeability in rats: the possible involvement of histamine release from mast cells. Eur J Pharmacol. 2000;407:327–32.

    Article  PubMed  CAS  Google Scholar 

  14. Adib-Conquy M, Cavaillon J-M. Stress molecules in sepsis and systemic inflammatory response syndrome. FEBS Lett. 2007;581:3723–33.

    Article  PubMed  CAS  Google Scholar 

  15. Jean-Baptiste E. Cellular mechanisms in sepsis. J Intensive Care Med. 2007;22:63–72.

    Article  PubMed  Google Scholar 

  16. Marshall JS, Jawdat DM. Mast cells in innate immunity. J Allergy Clin Immunol. 2004;114:21–7.

    Article  PubMed  CAS  Google Scholar 

  17. Aird WC. The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood. 2003;101:3765–77.

    Article  PubMed  CAS  Google Scholar 

  18. Brookes ZL, Stedman EN, Guerrini R, Lawton BK, Calo G, Lambert DG. Proinflammatory and vasodilator effects of nociceptin/orphanin FQ in the rat mesenteric microcirculation are mediated by histamine. Am J Physiol Heart Circ Physiol. 2007;293:H2977–85.

    Article  PubMed  CAS  Google Scholar 

  19. Calo G, Guerrini R, Rizzi A, Salvadori S, Burmeister M, Kapusta DR, Lambert DG, Regoli D. UFP-101, a peptide antagonist selective for the nociceptin/orphanin FQ receptor. CNS Drug Rev. 2005;11:97–112.

    Article  PubMed  CAS  Google Scholar 

  20. Brookes ZL, Stedman EN, Brown NJ, Hebbes CP, Guerrini R, Calo G, Reilly CS, Lambert DG. The nociceptin/orphanin FQ receptor antagonist UFP-101 reduces microvascular inflammation to lipopolysaccharide in vivo. PLoS One. 2013;8:e74943.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  21. Serhan CN, Fierro IM, Chiang N, Pouliot M. Cutting edge: nociceptin stimulates neutrophil chemotaxis and recruitment: inhibition by aspirin-triggered-15-epi-lipoxin A4. J Immunol. 2001;166:3650–4.

    Article  PubMed  CAS  Google Scholar 

  22. Kato S, Tsuzuki Y, Hokari R, Okada Y, Miyazaki J, Matsuzaki K, Iwai A, Kawaguchi A, Nagao S, Itoh K, Suzuki H, Nabeshima T, Miura S. Role of nociceptin/orphanin FQ (Noc/oFQ) in murine experimental colitis. J Neuroimmunol. 2005;161:21–8.

    Article  PubMed  CAS  Google Scholar 

  23. Fink M, Evans T. Mechanisms of organ dysfunction in critical illness: report from a Round Table Conference held in Brussels. Intensive Care Med. 2002;28:369–75.

    Article  PubMed  CAS  Google Scholar 

  24. Astiz ME, DeGent GE, Lin RY, Rackow EC. Microvascular function and rheologic changes in hyperdynamic sepsis. Crit Care Med. 1995;23:265–71.

    Article  PubMed  CAS  Google Scholar 

  25. Trombella S, Vergura R, Falzarano S, Guerrini R, Calo G, Spisani S. Nociceptin/orphanin FQ stimulates human monocyte chemotaxis via NOP receptor activation. Peptides. 2005;26:1497–502.

    Article  PubMed  CAS  Google Scholar 

  26. Brown KA, Brain SD, Pearson JD, Edgeworth JD, Lewis SM, Treacher DF. Neutrophils in development of multiple organ failure in sepsis. Lancet. 2006;368:157–69.

    Article  PubMed  CAS  Google Scholar 

  27. Thompson JP, Serrano-Gomez A, McDonald J, Ladak N, Bowrey S, Lambert DG. The nociceptin/orphanin FQ system is modulated in patients admitted to ICU with sepsis and after cardiopulmonary bypass. PLoS One. 2013;8:e76682.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  28. Cohen J. The immunopathogenesis of sepsis. Nature. 2002;420:885–91.

    Article  PubMed  CAS  Google Scholar 

  29. Jimenez MF, Watson RWG, Parodo J, Evans D, Foster D, Steinberg M, Rotstein OD, Marshall JC. Dysregulated expression of neutrophil apoptosis in the systemic inflammatory response syndrome. Arch Surg. 1997;132:1263.

    Article  PubMed  CAS  Google Scholar 

  30. Colotta F, Re F, Polentarutti N, Sozzani S, Mantovani A. Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. Blood. 1992;80:2012–20.

    PubMed  CAS  Google Scholar 

  31. Otsuka Y, Nagano K, Hori K, Oh-ishi J, Hayashi H, Watanabe N, Niitsu Y. Inhibition of neutrophil migration by tumor necrosis factor. Ex vivo and in vivo studies in comparison with in vitro effect. J Immunol. 1990;145:2639–43.

    PubMed  CAS  Google Scholar 

  32. Martins PS, Kallas EG, Neto MC, Dalboni MA, Blecher S, Salomao R. Upregulation of reactive oxygen species generation and phagocytosis, and increased apoptosis in human neutrophils during severe sepsis and septic shock. Shock. 2003;20:208–12.

    Article  PubMed  CAS  Google Scholar 

  33. Simms H, D’amico R. Polymorphonuclear leukocyte dysregulation during the systemic inflammatory response syndrome. Blood. 1994;83:1398–407.

    PubMed  CAS  Google Scholar 

  34. Nakamori Y, Koh T, Ogura H, Tanaka H, Fujimi S, Kasai K, Hosotubo H, Shimazu T, Sugimoto H. Enhanced Expression of Intranuclear NF-[kappa] B in Primed Polymorphonuclear Leukocytes in Systemic Inflammatory Response Syndrome Patients. J Trauma Acute Care Surg. 2003;54:253–60.

    Article  CAS  Google Scholar 

  35. Williams JP, Thompson JP, Young SP, Gold SJ, McDonald J, Rowbotham DJ, Lambert DG. Nociceptin and urotensin-II concentrations in critically ill patients with sepsis. Br J Anaesth. 2008;100:810–4.

    Article  PubMed  CAS  Google Scholar 

  36. Serhan CN. Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways. Annu Rev Immunol. 2007;25:101–37.

    Article  PubMed  CAS  Google Scholar 

  37. Amano H, Morimoto K, Senba M, Wang H, Ishida Y, Kumatori A, Yoshimine H, Oishi K, Mukaida N, Nagatake T. Essential contribution of monocyte chemoattractant protein-1/CC chemokine ligand-2 to resolution and repair processes in acute bacterial pneumonia. J Immunol. 2004;172:398–409.

    Article  PubMed  CAS  Google Scholar 

  38. Peluso J, LaForge KS, Matthes HW, Kreek MJ, Kieffer BL, Gavériaux-Ruff C. Distribution of nociceptin/orphanin FQ receptor transcript in human central nervous system and immune cells. J Neuroimmunol. 1998;81:184–92.

    Article  PubMed  CAS  Google Scholar 

  39. Strauss-Ayali D, Conrad SM, Mosser DM. Monocyte subpopulations and their differentiation patterns during infection. J Leukoc Biol. 2007;82:244–52.

    Article  PubMed  CAS  Google Scholar 

  40. Warren HS. Editorial: control issues in sepsis: what modulates apoptosis? J Leukoc Biol. 2011;89:325–6.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  41. Buzas B, Rosenberger J, Kim KW, Cox BM. Inflammatory mediators increase the expression of nociceptin/orphanin FQ in rat astrocytes in culture. Glia. 2002;39:237–46.

    Article  PubMed  Google Scholar 

  42. Dinarello CA. Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol. 2009;27:519–50.

    Article  PubMed  CAS  Google Scholar 

  43. Zhao H, Wu G-C, Cao X-D. Immunomodulatory activity of orphanin FQ/nociceptin on traumatic rats. Acta Pharmacol Sin. 2002;23:343.

    PubMed  CAS  Google Scholar 

  44. Goldfarb Y, Reinscheid RK, Kusnecov AW. Orphanin FQ/nociceptin interactions with the immune system in vivo: gene expression changes in lymphoid organs and regulation of the cytokine response to staphylococcal enterotoxin A. J Neuroimmunol. 2006;176:76–85.

    Article  PubMed  CAS  Google Scholar 

  45. Carvalho D, Petronilho F, Vuolo F, Machado RA, Constantino L, Guerrini R, Calo G, Gavioli EC, Streck EL, Dal-Pizzol F. The nociceptin/orphanin FQ-NOP receptor antagonist effects on an animal model of sepsis. Intensive Care Med. 2008;34:2284–90.

    Article  PubMed  CAS  Google Scholar 

  46. Kaminsky DE, Rogers TJ. Suppression of CCL2/MCP-1 and CCL5/RANTES expression by nociceptin in human monocytes. J Neuroimmune Pharmacol. 2008;3:75–82.

    Article  PubMed  Google Scholar 

  47. Al-Hashimi M, Scott S, Thompson J, Lambert D. Opioids and immune modulation: more questions than answers. Br J Anaesth. 2013;111:80–8.

    Article  PubMed  CAS  Google Scholar 

  48. Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med. 2003;348:138–50.

    Article  PubMed  CAS  Google Scholar 

  49. Németh J, Helyes Z, Oroszi G, Thán M, Pintér E, Szolcsányi J. Inhibition of nociceptin on sensory neuropeptide release and mast cell-mediated plasma extravasation in rats. Eur J Pharmacol. 1998;347:101–4.

    Article  PubMed  Google Scholar 

  50. Helyes Z, Németh J, Pintér E, Szolcsányi J. Inhibition by nociceptin of neurogenic inflammation and the release of SP and CGRP from sensory nerve terminals. Br J Pharmacol. 1997;121:613–5.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  51. Petrella C, Giuli C, Broccardo M, Eutamene H, Cartier C, Leveque M, Bedini A, Spampinato S, Bueno L, Theodorou V, Improta G, Agostini S. Protective and worsening peripheral nociceptin/orphanin FQ receptor-mediated effect in a rat model of experimental colitis. Pharmacol Res. 2013;70:72–9.

    Article  PubMed  CAS  Google Scholar 

  52. Kapusta DR. Neurohumoral effects of orphanin FQ/nociceptin: relevance to cardiovascular and renal function. Peptides. 2000;21:1081–99.

    Article  PubMed  CAS  Google Scholar 

  53. Hashiba E, Hirota K, Kudo T, Guerrini R, Matsuki A. Effects of nociceptin/orphanin FQ receptor ligands on blood pressure, heart rate, and plasma catecholamine concentrations in guinea pigs. Naunyn Schmiedebergs Arch Pharmacol. 2003;367:342–7.

    Article  PubMed  CAS  Google Scholar 

  54. Madeddu P, Salis MB, Milia AF, Emanueli C, Guerrini R, Regoli D, Calò G. Cardiovascular effects of nociceptin in unanesthetized mice. Hypertension. 1999;33:914–9.

    Article  PubMed  Google Scholar 

  55. Neal CR Jr, Akil H, Watson SJ Jr. Expression of orphanin FQ and the opioid receptor-like (ORL1) receptor in the developing human and rat brain. J Chem Neuroanat. 2002;22:219–49.

    Article  Google Scholar 

  56. Burmeister MA, Kapusta DR. Centrally administered nociceptin/orphanin FQ (N/OFQ) evokes bradycardia, hypotension, and diuresis in mice via activation of central N/OFQ peptide receptors. J Pharmacol Exp Ther. 2007;322:324–331.

    Article  PubMed  CAS  Google Scholar 

  57. Burmeister MA, Ansonoff MA, Pintar JE, Kapusta DR. Nociceptin/orphanin FQ (N/OFQ)-evoked bradycardia, hypotension, and diuresis are absent in N/OFQ peptide (NOP) receptor knockout mice. J Pharmacol Exp Ther. 2008;326:897–904.

    Article  PubMed  CAS  Google Scholar 

  58. Chu X, Xu N, Li P, Mao L, Wang JQ. Inhibition of cardiovascular activity following microinjection of novel opioid-like neuropeptide nociceptin (orphanin FQ) into the rat rostral ventrolateral medulla. Brain Res. 1999;829:134–42.

    Article  PubMed  CAS  Google Scholar 

  59. Laufenberg LJ, Weller GE, Lang CH, Ruiz-Velasco V. Nociceptin receptor signaling in sympathetic neurons from septic rats. J Surg Res. 2013;184:973–980.

    Google Scholar 

  60. Stamer UM, Book M, Comos C, Zhang L, Nauck F, Stuber F. Expression of the nociceptin precursor and nociceptin receptor is modulated in cancer and septic patients. Br J Anaesth. 2011;106:566–72.

    Article  PubMed  CAS  Google Scholar 

  61. Zhang L, Stuber F, Stamer UM. Inflammatory mediators influence the expression of nociceptin and its receptor in human whole blood cultures. PLoS One. 2013;8:e74138.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jonathan P. Thompson.

About this article

Cite this article

Thomas, R., Stover, C., Lambert, D.G. et al. Nociceptin system as a target in sepsis?. J Anesth 28, 759–767 (2014). https://doi.org/10.1007/s00540-014-1818-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00540-014-1818-6

Keywords

Navigation